Evolving preferences of HCPs during the pandemic have put an emphasis on learning new skillsets for pharma reps.
Jim Whitaker
Advertisement
Articles by Jim Whitaker
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
FDA Rejects AstraZeneca’s Application for Subcutaneous Indication of Saphnelo
3
From OR to Office: How Workflow Change and AI Are Reshaping MedTech Adoption
4
ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report
5